Exemption of sale license under schedule K of the Drugs Rules, 1945 for liquid antiseptic for household use

## Policy Analysis Report: Amendment to the Drugs Rules, 1945 **1. Executive Summary:** This report analyzes a draft notification amending the Drugs Rules, 1945, specifically focusing on exemptions for liquid antiseptics for household use. The amendment proposes to exempt these antiseptics from requiring a sale license under Chapter IV of the Drugs and Cosmetics Act, 1940, subject to specific conditions regarding manufacturing, content, packaging, and sourcing. This report details the background, key changes, affected stakeholders, and potential impact of this amendment. **2. Introduction:** The purpose of this report is to provide a comprehensive overview of a draft notification containing proposed amendments to the Drugs Rules, 1945, based on the text provided. This analysis focuses on understanding the nature of the amendment, its potential implications, and its impact on relevant stakeholders within the industry. **3. Policy Overview:** * The policy being amended is the Drugs Rules, 1945. * The core objective of this *amendment*, inferred from the provided text, is to provide exemptions from certain licensing requirements for liquid antiseptics intended for household use, potentially streamlining their availability and distribution. **4. Background and Rationale:** This is an amendment to the Drugs Rules, 1945. The likely reason for this specific amendment, based on the provided text, appears to be to ease regulatory burden on the sale of common household liquid antiseptics. The amendment addresses the requirement of a sale license in Form 20 or Form 20A under Chapter IV of the Act, suggesting that this requirement might have been perceived as unnecessarily restrictive for these types of products. The rationale is likely to balance public access to essential antiseptics with ensuring product quality and safety through specific conditions. **5. Key Provisions / Changes:** This amendment introduces the following key change to the Drugs Rules, 1945: * **Specific Part of Original Policy Changed:** Schedule K of the Drugs Rules, 1945. * **New Rule/Provision:** After serial number 38 in Schedule K, a new entry (39) is inserted for "Liquid Antiseptics." This new entry exempts these antiseptics from the provisions of Chapter IV of the Drugs and Cosmetics Act, 1940, and rules thereunder, which require them to be covered with a sale license in Form 20 or Form 20A for household use. * **Difference/Effect of the Change:** Liquid antiseptics for household use, that meet the following conditions, will no longer require a sale license (Form 20 or 20A) for sale: * The drugs are manufactured by licensed manufacturers. * The drugs do not contain any substance specified in Schedule G, H, H1 or X. * The drugs are sold in the original unopened containers of the licensed manufacturer. * The drugs are purchased from a licensed wholesaler or a licensed manufacturer. **6. Target Audience and Stakeholders:** Based on the text, the directly affected stakeholders include: * **Manufacturers of liquid antiseptics:** They can potentially benefit from reduced licensing requirements, but must adhere to the specified conditions. * **Wholesalers of liquid antiseptics:** They must be licensed to sell these products to retailers under the new exemptions. * **Retailers selling liquid antiseptics for household use:** They can now sell these products without a Form 20 or 20A license, as long as they purchase from licensed wholesalers or manufacturers and sell in the original packaging. * **Consumers:** Benefit from easier access to these antiseptic products. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The Ministry of Health and Family Welfare, specifically the Department of Health and Family Welfare, is responsible for implementing and overseeing these amendments. The Drugs Technical Advisory Board was consulted. * **Timelines/Procedures:** The draft rules were published on September 13, 2021, and were open for public comment for 30 days. The rules will come into force on the date of their final publication in the Official Gazette. * **Implementation specific to the changes:** Manufacturers of liquid antiseptics must ensure they meet the conditions for exemption, and retailers must verify their sources are licensed. Licensing authorities will need to adjust their procedures to reflect the new exemptions. **8. Expected Outcomes / Impact of Changes:** The likely intended outcome of these specific changes is to: * Reduce the regulatory burden on the sale of common household liquid antiseptics. * Improve access to these products for consumers. * Potentially lower the cost of compliance for manufacturers and retailers, leading to more competitive pricing. * The conditions attached to the exemption are intended to ensure that the quality and safety of these products are maintained. **9. Conclusion:** This amendment to the Drugs Rules, 1945, aims to streamline the sale of liquid antiseptics for household use by providing exemptions from specific licensing requirements under certain conditions. This change is likely to impact manufacturers, wholesalers, retailers, and ultimately, consumers, by easing access to these essential products while maintaining quality control. The industry should be cognizant of the specific conditions attached to the exemption to ensure compliance.

Key Entities Referenced